FIELD: medicine; medical engineering.
SUBSTANCE: biotransplant has genetically unmodified mesenchyma stem cell culture as active component obtained from fetal donor autologous material and genetically unmodified fetal myoblast culture. Method involves intravenously dropping mesenchyma stem cells in the amount of 50 to 500 mln in 50-100 ml of physiologic saline. The fetal myoblast culture is intramuscularly introduced at a dose of 100 mln of cells per 10 kg.
EFFECT: enhanced effectiveness in repairing incretory function of pancreas and reducing resistance to insulin; reduced risk of nephropathy and other complications.
9 cl
Title | Year | Author | Number |
---|---|---|---|
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC LOWER EXTREMITY ISCHEMIA CASES | 2005 |
|
RU2286159C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF OSTEOPOROSIS | 2004 |
|
RU2265442C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING PARODONTIUM DISEASES | 2004 |
|
RU2265445C1 |
BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
BIOTRANSPLANT, METHOD FOR ITS PREPARING AND METHOD FOR TREATMENT OF CHRONIC HEPATITIS AND LIVER CIRRHOSIS (VARIANTS) | 2004 |
|
RU2272638C1 |
BIOTRANSPLANT AND METHOD FOR TREATMENT OF LUNG HYPERTENSION | 2004 |
|
RU2271817C1 |
BIOTRANSPLANT, METHOD FOR PRODUCTION THEREOF (VARIANTS), AND METHOD FOR ALOPECIA TREATMENT | 2004 |
|
RU2271819C1 |
BIOTRANSPLANT AND METHOD FOR TREATMENT OF RHEUMATIC AND AUTOIMMUNE DISEASES | 2005 |
|
RU2298410C1 |
Authors
Dates
2005-12-10—Published
2004-05-14—Filed